Aeterna Zentaris posts net loss of $5.

LLC , that was entered into in March 2009, regarding the our now discontinued development program including cetrorelix for the treatment of Benign Prostatic Hyperplasia , and terminated subsequently. Research and development costs, net of tax credits and grants, had been $5.7 million for the three-month period ended March 31, 2010, compared to $11.4 million for the same period in 2009 2009. The comparative reduction in net R&D costs is almost entirely due to the winding down and termination of advancement activities related to cetrorelix in BPH, regardless of the existence in the first quarter of 2010 of residual expenditures associated with certain remaining contractual obligations.Qi and co-workers from School of Traditional Chinese Medicine Ji, Southern Medical University in China examined the consequences of acupuncture on human brain function in a pathological context, and compared the consequences between sham and Waiguan points in 16 individuals with ischemic stroke. Weighed against sham acupuncture, acupuncture at Waiguan in stroke patients inhibited Brodmann area 5 on the healthy side. These findings, published in the Neural Regeneration Study , indicated that the changed specificity of sensation-linked cortex is possibly associated with a central mechanism of acupuncture at Waiguan for stroke sufferers..